Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cinclus Pharma Holding AB ( (SE:CINPHA) ) just unveiled an announcement.
Cinclus Pharma Holding AB has announced an Extraordinary General Meeting scheduled for January 19, 2026, in Stockholm. The meeting will address several key agenda items, including the election of a new member to the Board of Directors and determining board remuneration. Shareholders are required to register by January 13, 2026, to participate, either in person or via postal voting.
The most recent analyst rating on (SE:CINPHA) stock is a Buy with a SEK60.00 price target. To see the full list of analyst forecasts on Cinclus Pharma Holding AB stock, see the SE:CINPHA Stock Forecast page.
More about Cinclus Pharma Holding AB
Average Trading Volume: 58,123
Technical Sentiment Signal: Buy
Current Market Cap: SEK791.1M
For a thorough assessment of CINPHA stock, go to TipRanks’ Stock Analysis page.

